Phase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of Presbyopia
Clinical trial NCT05656027 · COMPLETED
Trial details
- NCT number
- NCT05656027
- Sponsor
- LENZ Therapeutics, Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-19
- Primary completion
- 2023-12-15
- Enrollment
- 469
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.